News

UCLA TDG STAFF WORKING REMOTE

                   IMPORTANT ANNOUNCEMENT REGARDING

                   UCLA TECHNOLOGY DEVELOPMENT GROUP 

 

UCLA TDG is exercising caution with regard to novel coronavirus (COVID-19). Accordingly, most of our staff are working remotely. Remote TDG staff will use the Zoom Meeting client to conduct meetings, and are available via phone and email during regular business hours.

UCLA Researchers Currently Developing Rapid COVID-19 Testing

UCLA researchers in the Department of Molecular and Medical Pharmacology have discovered high affinity binding affibodies to COVID-19’s nucleocapsid protein that provide the basis for an ELISA-based diagnostic platform. The researchers are currently developing affibody-coated test strips for saliva detection of COVID-19 in high population settings or at home testing. More information can be found here

 

 

In Vivo Feature: How Proximity Creates Partnerships

How Proximity Creates Partnerships
VC Playbook: Sean Harper’s Bet On A Rising City Of Angels

21 Oct 2019 INTERVIEWS
by William Looney @BillInVivo william.looney@informa.com
Executive Summary

Former Amgen R&D lead Sean Harper talks exclusively to In Vivo about his new role as a venture capitalist, joining veteran industry investor Beth Seidenberg as co-founder of Los Angeles-based Westlake Village BioPartners.

Reprinted with permission from 

2020 Application Faculty Innovation Fund Open

We are happy to announce an open call for UCLA’s second cohort of Faculty Innovation Fellows (FIF). Started by the Technology Development Group, the Office of Research and Creative Activities, and Startup UCLA, the Faculty Innovation Fellows is a program aimed at advancing entrepreneurial excellence and startup culture among faculty across campus. A UCLA Newsroom story about last year’s program can be found here.